billHR9033•Event Tuesday, May 26, 2026Analyzed

To amend title 38, United States Code, to enhance the sharing of health-care resources between the Department of Veterans Affairs and State Veterans Homes, and for other purposes.

Neutral

Summary

HR9033 is an early-stage bill referred to committee with no specific funding authorization. It aims to enhance VA-State Veterans Home resource sharing but contains no direct market-moving provisions. No actionable market impact at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

1.HR9033 is procedural with no near-term market impact.
2.No specific funding is authorized; any spending requires future appropriations.
3.No publicly traded companies are directly affected by this bill.

Market Implications

No market implications at this stage. The bill does not authorize spending, create tax incentives, or mandate private sector involvement. Healthcare tickers (UNH, JNJ, ABBV, LLY, MRK, PFE, HCA, MDT, ABT) are unaffected.

Full Analysis

1) On 2026-05-26, Representative Miller-Meeks (R-IA) introduced HR9033 in the 119th Congress. The bill was referred to the House Committee on Veterans' Affairs. It is in the earliest legislative stage with no hearings, markups, or companion Senate bill. 2) The bill authorizes no specific dollar amount. It addresses administrative coordination between the VA and State Veterans Homes for sharing healthcare resources. Any funding would require a separate appropriations bill. 3) No publicly traded companies are directly named or clearly affected. The bill's scope is limited to government-to-government resource sharing, not procurement or contracting with private sector healthcare providers. 4) No real market data is provided for this bill. The healthcare sector data shows large diversified companies (UNH, JNJ, ABBV, etc.) but none have a direct revenue link to VA-State Veterans Home resource sharing. 5) The bill must pass committee, then the full House, then the Senate, then be signed into law. Given the early stage and lack of companion bill, the legislative path is long and uncertain.

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

BillStrong LinkNeutral

To amend titles XVIII and XIX of the Social Security Act to streamline the certification process for State Veterans Homes by allowing certain facilities certified by the Department of Veterans Affairs to be deemed in compliance with specified Medicare and Medicaid requirements, and for other purposes.

Shared: State Veterans · Veterans Homes · Veterans28% match

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

$BA $LMT $RTX $GD $NOC $SAIC

8/10Source

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

$CMPS $MNMD $GHRS $ATAI $CYBN $NUMI

8/10Source